Skip to content
Tenfell
Awarded contract
Published 10 Jun 2026

Blood Group Genotyping for Sickle Cell and Thalassaemia

NHS England · London

Key facts

Contract value
£140,671
Awarded
09 Jun 2026
Contract starts
09 Jun 2026
Contract ends
11 Jun 2026
Procedure
Direct award
Buyer type
Central government

Awarded to

SupplierValue
NHSBT£140,671

Description

Embedding blood group genotyping into routine practice. The primary objective (benefit) of doing so is to ensure patients with rare blood disorders have a minimise risk of adverse reactions through access to blood group genotyping. Due to delays arising from administrative and operational circumstances, NHS England awarded this contract to commencing 25 June 2025 until 31 March 2026.

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Find a Tender (Open Government Licence v3.0). Always read the original notice before responding.